Glyburide
FDA Label NDC 61919-378
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Direct_rx for the product Glyburide (NDC 61919-378). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, precautions, adverse reactions, overdosage, dosage and administration, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Clinical Pharmacology
Indications And Usage
Contraindications
Precautions
Adverse Reactions
Overdosage
Dosage And Administration
Package Label
Label (Glyburide378)
* Please review the disclaimer below.
